We present a patient with 3M syndrome caused by the compound heterozygous mutations p.Trp68* and p.Gly1452Asp in <i>CUL7</i>, the latter of which is novel, who exhibited a good body height response to growth hormone treatment. Here, GH1 is linked to 3M syndrome.